These results reveal that highly expressed ASPM in the drug-resistant cell line PC-9 OR plays an indispensable role in maintaining the stability of EGFR proteins and that highly expressed ASPM-2 plays a key role in the cell cycle regulation and drug resistance of cancer cells, which provides a theoretical basis for the targeting of ASPM in the treatment of drug resistance. This evidence concerns the gene ASPM and cancer.